 |
Thursday, February 12, 2009
Paper written by SUNY Stony Brook gynecology/oncology team using Vitatex technology is accepted for publication in the journal, Cancer Letters
|
|
Paper titled “Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer” available online Here
 Read More
|
Monday, February 02, 2009
Paper by SUNY Stony Brook gynecology/oncology team published in Gynecologic Oncology
|
|
Paper titled “Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer” available online Here
Read More
|
Saturday, October 11, 2008
Vitatex launches new series of Vita-Cap™ F products for the functional enrichment of human tumor and other rare viable cells from whole blood, lymph, bone marrow and other body fluids.
|
|
Enriched cells can be released by enzymes (or their DNA/RNA/Protein extracted directly from cells adherent to the CAM-coated wall) for culturing, cytological and molecular analyses. .
Read More
|
Thursday, September 11, 2008
SUNY Stony Brook gynecology/oncology team’s paper using Vitatex technology is accepted for publication in the journal of Gynecologic Oncology.
|
|
Paper discusses the clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer. .
Read More
|
Tuesday, July 08, 2008
SUNY Stony Brook medical oncology team’s paper using Vitatex technology is accepted for publication in the International Journal of Cancer.
|
|
Paper describes the use of CAM to isolate tumor cells from peritoneal ascites of an ovarian cancer patient to demonstrate the elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells. .
Read More
|
Saturday, December 01, 2007
SUNY Stony Brook medical oncology team presents clinical results of breast cancer using Vitatex technology
|
|
The prognostic value of invasive circulating tumor cells in early stage breast cancer patients is presented at “The San Antonio Breast Cancer Symposium”, in San Antonio, Taxes.
Read More
|
Wednesday, September 19, 2007
Vitatex presents clinical results of ovarian cancer using Vitatex technology at ISMRC
|
|
The clinical significance of disseminating ovarian tumor cells detected by CAM technology is presented at “6th International Symposium on Minimal Residual Cancer” in Hamburg, Germany.
Read More
|
Tuesday, July 31, 2007
US patent No.7, 250,492 “Compositions and Methods for Inhibition of Cancer Invasion and Angiogenesis” is granted, which Vitatex holds the world-wide exclusive license from the State University of New York at Stony Brook.
|
Read More
|
Thursday, December 14, 2006
SUNY Stony Brook medical oncology team presents clinical results of breast cancer using Vitatex technology
|
|
The prognostic value of invasive circulating tumor cells in breast cancer patients is presented at “The San Antonio Breast Cancer Symposium” in San Antonio, Taxes.
Read More
|
